Literature DB >> 7599295

Predictors of postoperative morbidity and mortality after surgery for gastro-oesophageal carcinomas.

B L Liedman1, K Bennegård, L C Olbe, L R Lundell.   

Abstract

OBJECTIVE: To define risk factors for postoperative morbidity and mortality in patients undergoing standardised laparotomy/gastrectomy or thoracoabdominal resection for carcinomas of the stomach, oesophagus, and oesophagogastric junction.
DESIGN: Prospective open study.
SETTING: University hospital, Sweden.
SUBJECTS: All 213 patients operated on for carcinoma of the stomach, oesophagus, or oesophagogastric junction between January 1983 and June 1990.
INTERVENTIONS: Laparotomy/gastrectomy (n = 132) or thoracoabdominal resection (n = 81). MAIN OUTCOME MEASURES: Postoperative morbidity and mortality.
RESULTS: 8 Patients died after laparotomy/gastrectomy, and 10 after thoracoabdominal resection. Complications were more common after thoracoabdominal resection (101 in 81 patients) than after laparotomy/gastrectomy (108 in 132 patients). The most common complication in both groups was pneumonia (29/132, 22%, compared with 22/81, 27%), but this could be predicted only in the group that underwent thoracoabdominal resection. Significant risk factors in this group were: an abnormal chest radiograph preoperatively (p = 0.0007), a high risk predicted by the anaesthetist (p = 0.005), and signs of obstruction on spirometry (p = 0.002). In the thoracoabdominal group a history of pulmonary disease, the patient's age, and general physical performance assessed by the exercise test significantly predicted a high risk of postoperative death. Risk profile curves for mortality were generated for patients aged 55, 65, or 75 years with and without pre-existing pulmonary disease and adjusted for working capacity (W) so that patients at high risk of dying after thoracoabdominal resection could easily be identified. Any patient with a history of pulmonary disease and a working capacity of less than 80 W whatever their age should be advised against thoracoabdominal resection, whereas in those without a history of pulmonary disease and a working capacity of more than 80 W, a good recovery may be anticipated. The cut off point for working capacity seems to be 80 W.
CONCLUSION: With simple clinical guidelines it is possible to draw risk profiles for patients about to undergo thoracoabdominal resections for carcinoma of the oesophagus or oesophagogastric junction.

Entities:  

Mesh:

Year:  1995        PMID: 7599295

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  10 in total

1.  Subtotal or total gastrectomy for gastric cancer: impact of the surgical procedure on morbidity and prognosis--analysis of a 10-year experience.

Authors:  Ines Gockel; Sebastian Pietzka; Ursula Gönner; Gerhard Hommel; Theodor Junginger
Journal:  Langenbecks Arch Surg       Date:  2005-02-12       Impact factor: 3.445

2.  Physical decline and its implications in the management of oesophageal and gastric cancer: a systematic review.

Authors:  Linda O'Neill; Jonathan Moran; Emer M Guinan; John V Reynolds; Juliette Hussey
Journal:  J Cancer Surviv       Date:  2018-05-23       Impact factor: 4.442

3.  Determination of the optimal surgical procedure by identifying risk factors for pneumonia after transthoracic esophagectomy.

Authors:  Masato Hayashi; Hiroya Takeuchi; Rieko Nakamura; Koichi Suda; Norihito Wada; Hirofumi Kawakubo; Yuko Kitagawa
Journal:  Esophagus       Date:  2019-09-09       Impact factor: 4.230

4.  Enhanced recovery for non-colorectal surgery.

Authors:  Gianpiero Gravante; Muhammad Elmussareh
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

5.  Quality of life in gastric cancer prior to gastrectomy.

Authors:  J Svedlund; M Sullivan; I Sjödin; B Liedman; L Lundell
Journal:  Qual Life Res       Date:  1996-04       Impact factor: 4.147

6.  Treatment of postoperative esophagorespiratory fistulas with dual self-expanding metal stents.

Authors:  Thorhallur Agustsson; Magnus Nilsson; Gert Henriksson; Urban Arnelo; Jan E Juto; Lars Lundell
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

7.  Non-malignant respiratory tract fistula from the oesophagus. A lethal condition for which novel therapeutic options are emerging.

Authors:  Peter Elbe; Mats Lindblad; Jon Tsai; Jan-Erik Juto; Gert Henriksson; Thorhallur Agustsson; Lars Lundell; Magnus Nilsson
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-25

8.  Effects on heart function of neoadjuvant chemotherapy and chemoradiotherapy in patients with cancer in the esophagus or gastroesophageal junction - a prospective cohort pilot study within a randomized clinical trial.

Authors:  Mikael Lund; Gabriella Alexandersson von Döbeln; Magnus Nilsson; Reidar Winter; Lars Lundell; Jon A Tsai; Sigridur Kalman
Journal:  Radiat Oncol       Date:  2015-01-13       Impact factor: 3.481

9.  Effects of high-intensity exercise training on physical fitness, quality of life and treatment outcomes after oesophagectomy for cancer of the gastro-oesophageal junction: PRESET pilot study.

Authors:  C Simonsen; S Thorsen-Streit; A Sundberg; S S Djurhuus; C E Mortensen; C Qvortrup; B K Pedersen; L B Svendsen; P de Heer; J F Christensen
Journal:  BJS Open       Date:  2020-08-28

10.  Does Cardiopulmonary Testing Help Predict Long-Term Survival After Esophagectomy?

Authors:  Jakub Chmelo; Rachel A Khaw; Rhona C F Sinclair; Maziar Navidi; Alexander W Phillips
Journal:  Ann Surg Oncol       Date:  2021-05-26       Impact factor: 5.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.